Niagen Bioscience sells ChromaDex Reference Standards business to LGC in all-cash deal

Niagen Bioscience, Inc.

All-cash sale closed Feb 24, 2026; buyer is VHG Labs, part of LGC Group.
Divestiture exits non-core activities; focuses on NAD+ science, IP, commercial growth.
Transition services agreement for up to 6 months; service fee recognized as performed.
No purchase price or financial terms disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.